Abstract
Single Doses of Antibody Drug Conjugates (ADCs) Targeted to CD117 or CD45 Have Potent In Vivo Anti-Leukemia Activity and Survival Benefit in Patient Derived AML Models
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have